Primary Thyroid Angiosarcoma: A Systematic Review

Overview

Journal Oral Oncol

Publisher Elsevier

Specialty Dentistry

Date 2018 Jun 19

PMID 29909901

Citations 11

Authors

F De Felice

E Moscatelli

S Orelli

N Bulzonetti

D Musio

V Tombolini

Affiliations

Soon will be listed here.

Abstract

Thyroid angiosarcoma (TAS) is rare and represents a very aggressive malignancy. Its rarity is principally linked to two major pitfalls. Firstly, TAS histopathology diagnosis can be difficult; second, the limited clinical experience with this condition can make its management complex. We conducted a detailed systematic review, focusing on the knowledge available regarding TAS etiopathogenesis, treatment options and prognosis. The aim is to present the main TAS characteristics and to summarize the clinical experiences described worldwide, in order to provide a useful clinical tool.

Citing Articles

On Vascular Lesions of the Thyroid Gland with Emphasis on Intrathyroidal Hemangioma: Clinicopathologic Characterization of Two Cases and Review of the Literature.

MacDonald W, Wakely P, Argyris P Head Neck Pathol. 2024; 18(1):108.

PMID: 39422760 PMC: 11489361. DOI: 10.1007/s12105-024-01722-6.

Neck Surgery for Non-Well Differentiated Thyroid Malignancies: Variations in Strategy According to Histopathology.

Lopez F, Al Ghuzlan A, Zafereo M, Vander Poorten V, Robbins K, Hamoir M Cancers (Basel). 2023; 15(4).

PMID: 36831604 PMC: 9954150. DOI: 10.3390/cancers15041255.

Non-alpine primary thyroid angiosarcoma.

Mourinho Bala N, Simoes P, Aragues J, Veiga R, Guerra S, Valadas C Arch Endocrinol Metab. 2022; 66(3):425-428.

PMID: 35612841 PMC: 9832846. DOI: 10.20945/2359-3997000000460.

Primary Mesenchymal Tumors of the Thyroid Gland: A Modern Retrospective Cohort Including the First Case of TFE3-Translocated Malignant Perivascular Epithelioid Cell Tumor (PEComa).

Zhang L, Lubin D, Sinard J, Dickson B, Antonescu C, Wu H Head Neck Pathol. 2022; 16(3):716-727.

PMID: 35218514 PMC: 9424363. DOI: 10.1007/s12105-022-01428-7.

Morphology and one immunohistochemical marker are enough for diagnosis of primary thyroid angiosarcoma.

Negura I, Badescu M, Rezus C, Danila R, Florescu A, Blaj M Arch Clin Cases. 2021; 8(1):7-13.

PMID: 34754933 PMC: 8565704. DOI: 10.22551/2021.30.0801.10178.